A CpG-Oligodeoxynucleotide Suppresses Th2/Th17 Inflammation by Inhibiting IL-33/ST2 Signaling in Mice from a Model of Adoptive Dendritic Cell Transfer of Smoke-Induced Asthma.
A CpG-Oligodeoxynucleotide Suppresses Th2/Th17 Inflammation by Inhibiting IL-33/ST2 Signaling in Mice from a Model of Adoptive Dendritic Cell Transfer of Smoke-Induced Asthma.
复制标题
DOI:
10.3390/ijms24043130
复制
发表时间:
2023-02-04
影响因子:
5.6
通讯作者:
Li, Hongtao
中科院分区:
文献类型:
--
作者:
Yang, Xuena;Su, Beiting;Liu, Jing;Zheng, Li;Tao, Peizhi;Lin, Yusen;Zou, Xiaoling;Yang, Hailing;Wu, Wenbin;Meng, Ping;Zhang, Tiantuo;Li, Hongtao
Tobacco smoke exposure is a major environmental risk factor that facilitates the development and progression of asthma. Our previous study showed that CpG oligodeoxynucleotide (CpG-ODN) inhibits thymic stromal lymphopoietin (TSLP)-dendritic cells (DCs) to reduce Th2/Th17-related inflammatory response in smoke-related asthma. However, the mechanism underlying CpG-ODN -downregulated TSLP remains unclear. A combined house dust mite (HDM)/cigarette smoke extract (CSE) model was used to assess the effects of CpG-ODN on airway inflammation, Th2/Th17 immune response, and amount of IL-33/ST2 and TSLP in mice with smoke-related asthma induced by adoptive transfer of bone-marrow-derived dendritic cells (BMDCs) and in the cultured human bronchial epithelium (HBE) cells administered anti-ST2, HDM, and/or CSE. In vivo, compared to the HDM alone model, the combined HDM/CSE model had aggravated inflammatory responses, while CpG-ODN attenuated airway inflammation, airway collagen deposition, and goblet cell hyperplasia and reduced the levels of IL-33/ST2, TSLP, and Th2/Th17-cytokines in the combined model. In vitro, IL-33/ST2 pathway activation promoted TSLP production in HBE cells, which could be inhibited by CpG-ODN. CpG-ODN administration alleviated Th2/Th17 inflammatory response, decreased the infiltration of inflammatory cells into the airway, and improved the remodeling of smoke-related asthma. The underlying mechanism may be that CpG-ODN inhibits the TSLP-DCs pathway by downregulating the IL-33/ST2 axis.
登录
查看更多内容
DOI:
10.4049/jimmunol.1100355
发表时间:
2011-08-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Kashyap M;Rochman Y;Spolski R;Samsel L;Leonard WJ
通讯作者:
Leonard WJ
影响因子:
14.2
作者:
Beeh, Kai-Michael;Kanniess, Frank;Renner, Wolfgang A.
通讯作者:
Renner, Wolfgang A.
DOI:
10.1164/rccm.200904-0552oc
发表时间:
2009-12-15
影响因子:
24.7
作者:
Freeman, Christine M.;Martinez, Fernando J.;Curtis, Jeffrey L.
通讯作者:
Curtis, Jeffrey L.
影响因子:
2.9
作者:
Feng, Shuang;Zhang, Li;Shi, Rui-Ming
通讯作者:
Shi, Rui-Ming
影响因子:
4.6
作者:
Kim SY;Sim S;Choi HG
通讯作者:
Choi HG